Forte Biosciences (FBRX) Income towards Parent Company (2016 - 2020)
Historic Income towards Parent Company for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$9.4 million.
- Forte Biosciences' Income towards Parent Company rose 4500.7% to -$9.4 million in Q1 2020 from the same period last year, while for Dec 2020 it was -$9.4 million, marking a year-over-year increase of 8520.85%. This contributed to the annual value of -$63.5 million for FY2019, which is 2974.36% down from last year.
- Per Forte Biosciences' latest filing, its Income towards Parent Company stood at -$9.4 million for Q1 2020, which was up 4500.7% from -$10.6 million recorded in Q4 2019.
- Forte Biosciences' 5-year Income towards Parent Company high stood at -$383000.0 for Q3 2018, and its period low was -$19.6 million during Q4 2018.
- Its 5-year average for Income towards Parent Company is -$11.4 million, with a median of -$10.0 million in 2017.
- Its Income towards Parent Company has fluctuated over the past 5 years, first skyrocketed by 9615.19% in 2018, then tumbled by 479164.49% in 2019.
- Quarter analysis of 5 years shows Forte Biosciences' Income towards Parent Company stood at -$8.5 million in 2016, then fell by 28.08% to -$10.8 million in 2017, then tumbled by 80.89% to -$19.6 million in 2018, then surged by 46.01% to -$10.6 million in 2019, then rose by 11.23% to -$9.4 million in 2020.
- Its last three reported values are -$9.4 million in Q1 2020, -$10.6 million for Q4 2019, and -$18.7 million during Q3 2019.